21 – 30 of 268
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Analysis of vitamin D and its metabolites in biological samples – Part II : Optimization of a sample preparation method for liver tissue
2024) In Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 1237.(
- Contribution to journal › Article
-
Mark
Analysis of vitamin D and its metabolites in biological samples – Part I : Optimization and comparison of UHPSFC-MS/MS and UHPLC-MS/MS methods
2024) In Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 1237.(
- Contribution to journal › Article
- 2023
-
Mark
Affinity-Purification Combined with Crosslinking Mass Spectrometry for Identification and Structural Modeling of Host-Pathogen Protein-Protein Complexes
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The Phosphoproteome of the Rd1 Mouse Retina, a Model of Inherited Photoreceptor Degeneration, Changes after Protein Kinase G Inhibition
(
- Contribution to journal › Article
-
Mark
NO at low concentration can enhance the formation of highly oxygenated biogenic molecules in the atmosphere
(
- Contribution to journal › Article
- 2022
-
Mark
Lipidomes of Icelandic bryophytes and screening of high contents of polyunsaturated fatty acids by using lipidomics approach
(
- Contribution to journal › Article
-
Mark
The accuracy and robustness of plasma biomarker models for amyloid PET positivity
(
- Contribution to journal › Article
-
Mark
Testosterone associates differently with body mass index and age in serum and cerebrospinal fluid in men
(
- Contribution to journal › Letter
-
Mark
Genes and proteins controlled by cGMP-PKG during retinal degeneration
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance
(
- Contribution to journal › Article